Specialty
Certifications
Infectious Disease
American Board of Internal Medicine
Education
MD, Albert Einstein College of Medicine
M.S., The Mount Sinai School of Medicine
Clinical ResearchInternship, Internal Medicine
Mount Sinai HospitalResidency, Internal Medicine
Mount Sinai HospitalFellowship, Infectious Diseases
Mount Sinai Hospital
Biography
- Dr. Patel specializes in the treatment of infections in immune-compromised patients like those who anticipate or should undergo solid organ or hematopoietic stem cell transplantation. She is also the medical director of the Mount Sinai Antimicrobial stewardship program where there is an emphasis placed on education of medical staff on the appropriate use of antimicrobials, cost-effectiveness and evidence-based management of infections.
Dr. Patel's research interests include healthcare-associated infections, multi-drug resistant bacterial infections and infections in the solid organ transplantation.
Awards
2009 -
SHEA Barry Farr Award
2008 -
Annual Fellow's Award for Research
Infectious Diseases Society of New York2007 - 2008
Trainee Grant
Advancing Clinical Excellence in Medicine2007 -
Research Day Honoree
The Mount Sinai School of Medicine Department of Medicine
Publications
Patel G, Huprikar S. Prevention and Management of Infections in Solid Organ Transplantation. Hospital Physician Board Review Manual: Infectious Diseases 2008; 11(5): 2-12.
Patel G, Huprikar S, Jenkins SG, Factor SH, Calfee DP. Outcomes of Carbapenem-Resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infection Control and Hospital Epidemiology 2008; 29(12): 1099-1106.
Patel G, Arvelakis A, Sauter B, Gondolesi G, Caplivski D, Huprikar S. Case Report: Strongyloides hyperinfection syndrome after intestinal transplantation. Transplant Infectious Diseases 2008; 10(2): 137-141.
Wiener M, Guo Y, Patel G, Fries BC. Lactic acidosis after treatment with linezolid. Infection 2007; 35: 278-281.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Patel did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 23rd Floor Room Room 345C
1468 Madison Avenue
New York, NY 10029
Fax: 212-534-3240
